skin-microbiome
(3)
Arcaea’s $78 million bet on a different kind of scent
Extinct flowers became perfume. Underarm microbes became a design problem. Arcaea is turning biology into ingredients for beauty brands - and stories for its own.
The Lab That Turns Beauty Claims Into Receipts
Most beauty brands sell a promise. This 26-person Valencia lab sells the evidence behind it - and turned customized efficacy testing into a cross-border business.
Cheri Ackerman Araromi
Cheri Ackerman Araromi is the cofounder and CEO of Concerto Biosciences, a Cambridge, Massachusetts biotech that reads the social lives of microbes the way a producer reads a band. Using kChip, a droplet screening platform she helped build during her postdoc at the Broad Institute, Concerto tests how thousands of microbial combinations interact and assembles the winning ensembles into products for skin health, agriculture, and beyond. A Hertz Fellow with a Berkeley PhD in chemical biology, she frames the future of medicine as building healthy ecosystems rather than killing bad cells with toxins.